Survivorship Analysis in Asymptomatic COVID-19+ Hip Fracture Patients: Is There an Increase in Mortality?
Mason D VialongaLuke G MenkenAlex TangJohn W YurekLi SunJohn J FeldmanFrank A LiporaceRichard S YoonPublished in: Hip & pelvis (2022)
Factors including time to surgery, age, preexisting comorbidities, and postoperative ambulatory status have been proven to affect mortality and complications in hip fracture patients; however, a positive COVID-19 test result adds another variable to this process. Implementation of protocols that will promote prompt orthogeriatric assessments, expedite patient transfer, limit operating room traffic, and optimize anesthesia time can preserve the standard of care in this unique patient population.
Keyphrases
- hip fracture
- end stage renal disease
- coronavirus disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- sars cov
- healthcare
- prognostic factors
- risk factors
- palliative care
- primary care
- quality improvement
- patients undergoing
- cardiovascular events
- cardiovascular disease
- minimally invasive
- pain management
- health insurance
- childhood cancer